- Home
- MERC vs ARCT Comparison
MERC vs ARCT Comparison
Compare MERC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- ARCT
- Stock Information
- Founded
- MERC 1968
- ARCT 2013
- Country
- MERC Canada
- ARCT United States
- Employees
- MERC N/A
- ARCT N/A
- Industry
- MERC Paper
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MERC Basic Materials
- ARCT Health Care
- Exchange
- MERC Nasdaq
- ARCT Nasdaq
- Market Cap
- MERC 271.5M
- ARCT 298.3M
- IPO Year
- MERC 1987
- ARCT N/A
- Fundamental
- Price
- MERC $3.58
- ARCT $12.53
- Analyst Decision
- MERC Hold
- ARCT Strong Buy
- Analyst Count
- MERC 3
- ARCT 8
- Target Price
- MERC $5.33
- ARCT $52.33
- AVG Volume (30 Days)
- MERC 707.8K
- ARCT 450.8K
- Earning Date
- MERC 05-01-2025
- ARCT 05-12-2025
- Dividend Yield
- MERC 8.37%
- ARCT N/A
- EPS Growth
- MERC N/A
- ARCT N/A
- EPS
- MERC N/A
- ARCT N/A
- Revenue
- MERC $1,996,904,000.00
- ARCT $143,680,000.00
- Revenue This Year
- MERC $2.43
- ARCT N/A
- Revenue Next Year
- MERC $6.12
- ARCT $42.36
- P/E Ratio
- MERC N/A
- ARCT N/A
- Revenue Growth
- MERC N/A
- ARCT 15.38
- 52 Week Low
- MERC $3.20
- ARCT $8.04
- 52 Week High
- MERC $9.78
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- MERC 34.30
- ARCT 54.31
- Support Level
- MERC $3.47
- ARCT $11.51
- Resistance Level
- MERC $4.22
- ARCT $13.00
- Average True Range (ATR)
- MERC 0.17
- ARCT 0.98
- MACD
- MERC 0.03
- ARCT 0.08
- Stochastic Oscillator
- MERC 14.67
- ARCT 57.74
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.